Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna says it’s ‘one step closer’ to a norovirus vaccine
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
Stomach bug,” “cruise-ship virus,” “winter vomiting disease”—all are nicknames for norovirus, the top cause of vomiting, diarrhea, and foodborne illness in the U.S. The contagious ailment typically circulates throughout the late fall,
How close are we to a norovirus vaccine?
Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people worldwide every year, and though there is currently no preventive vaccine, a promising contender is in the works.
A Norovirus Vaccine Is in the Works
Norovirus is surging across the U.S., with case numbers higher now than they've been at the same time in more than a decade, according to the U.S. Centers for Disease Control and Prevention (CDC). There is no antiviral treatment for the miserable but thankfully short-lived illness,
4d
on MSN
Moderna Is Gambling on China as Other U.S. Companies Pull Back
The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
STAT
3d
Pharmalittle: We’re reading about pharma layoffs, Moderna gambling on China, and more
The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...
2d
Moderna: Can They Benefit From Bird Flu? (Rating Upgrade)
Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...
2d
on MSN
The Score: Meta Platforms, Moderna, Edison International and More Stocks That Defined the Week
Here are some of the major companies whose stocks moved on the week’s news.
3d
What’s Behind The Recent Rise In MRNA Stock?
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
FiercePharma
5d
After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
2d
Moderna Inc. stock underperforms Friday when compared to competitors
Shares of Moderna Inc. MRNA slid 2.13% to $42.25 Friday, on what proved to be an all-around rough trading session for the ...
9d
Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
5d
on MSN
Moderna and other vaccine maker shares jump after first US bird flu death
Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...
4d
After a rough 2024, Moderna lays out plans for 2025
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
China
United States
COVID
Pfizer
NASDAQ
Feedback